Private hospital group Mediclinic is poised to challenge the Competition Tribunal’s prohibition of its proposed acquisition of Matlosana Medical Health Services (MMHS) at the Competition Appeal Court, as it fights to expand its footprint in the North West.

The battle between Mediclinic and the competition authorities highlights the conundrum facing all three JSE-listed hospital groups — Mediclinic, Netcare and Life Healthcare — as they face regulatory constraints to domestic expansion and have struggled to succeed in many of their offshore ventures...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now